Viva Biotech Holdings Cash Flow Reinvestment Rate
Viva Biotech Holdings cash flow reinvestment rate. Viva Biotech Holdings (VB0) has a Cash Flow Reinvestment Rate of 0.37x as of June 2023, reinvesting €57.96 Million (capex €50.80 Million plus investments €7.15 Million) from operating cash flow of €158.72 Million. Explore debt repayment capacity of Viva Biotech Holdings to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Viva Biotech Holdings (2016–2024)
Cash flow reinvestment rate of Viva Biotech Holdings from 2016 to 2024. Historical reinvestment intensity for Viva Biotech Holdings across 9 annual periods. Explore Viva Biotech Holdings (VB0) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Viva Biotech Holdings Cash Flow Reinvestment Rate by Year (2016–2024)
Viva Biotech Holdings cash flow reinvestment rate by year from 2016 to 2024. Year-by-year capital reinvestment analysis for Viva Biotech Holdings. For the full cash flow conversion analysis, see Viva Biotech Holdings (VB0) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | €340.66 Million | €373.99 Million | €191.67 Million | ▲ +45.0% |
| 2023 | 0.63x | €240.78 Million | €383.40 Million | €187.84 Million | ▼ -18.5% |
| 2022 | 0.77x | €297.35 Million | €386.05 Million | €249.33 Million | ▼ -91.7% |
| 2021 | 9.31x | €724.23 Million | €77.83 Million | €565.18 Million | ▼ -44.0% |
| 2020 | 16.61x | €717.04 Million | €43.18 Million | €592.62 Million | ▲ +219.8% |
| 2019 | 5.19x | €238.95 Million | €46.01 Million | €56.19 Million | ▼ -14.4% |
| 2018 | 6.07x | €73.46 Million | €12.11 Million | €46.90 Million | ▲ +484.9% |
| 2017 | 1.04x | €28.92 Million | €27.89 Million | €18.92 Million | ▼ -18.7% |
| 2016 | 1.28x | €26.93 Million | €21.12 Million | €7.34 Million | — |